Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.01 EUR
−215.53 M EUR
233.07 M EUR
110.57 M
About Coherus BioSciences, Inc.
Sector
CEO
Denny M. Lanfear
Headquarters
Redwood City
Website
Founded
2010
FIGI
BBG007J27QP7
Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
CHRS5172388
Coherus BioSciences, Inc. 1.5% 15-APR-2026Yield to maturity
4.09%
Maturity date
Apr 15, 2026
Explore more bonds
Frequently Asked Questions
The current price of 8C5 is 1.42 EUR — it has decreased by −3.72% in the past 24 hours. Watch COHERUS BIOSCIENCES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange COHERUS BIOSCIENCES INC stocks are traded under the ticker 8C5.
8C5 stock has risen by 7.79% compared to the previous week, the month change is a −11.63% fall, over the last year COHERUS BIOSCIENCES INC has showed a −44.83% decrease.
We've gathered analysts' opinions on COHERUS BIOSCIENCES INC future price: according to them, 8C5 price has a max estimate of 7.61 EUR and a min estimate of 5.71 EUR. Watch 8C5 chart and read a more detailed COHERUS BIOSCIENCES INC stock forecast: see what analysts think of COHERUS BIOSCIENCES INC and suggest that you do with its stocks.
8C5 stock is 0.11% volatile and has beta coefficient of 1.71. Track COHERUS BIOSCIENCES INC stock price on the chart and check out the list of the most volatile stocks — is COHERUS BIOSCIENCES INC there?
Today COHERUS BIOSCIENCES INC has the market capitalization of 168.91 M, it has decreased by −13.30% over the last week.
Yes, you can track COHERUS BIOSCIENCES INC financials in yearly and quarterly reports right on TradingView.
COHERUS BIOSCIENCES INC is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
8C5 earnings for the last quarter are −0.08 EUR per share, whereas the estimation was −0.15 EUR resulting in a 44.91% surprise. The estimated earnings for the next quarter are −0.30 EUR per share. See more details about COHERUS BIOSCIENCES INC earnings.
COHERUS BIOSCIENCES INC revenue for the last quarter amounts to 63.57 M EUR, despite the estimated figure of 52.97 M EUR. In the next quarter, revenue is expected to reach 42.65 M EUR.
8C5 net income for the last quarter is −9.66 M EUR, while the quarter before that showed −12.06 M EUR of net income which accounts for 19.95% change. Track more COHERUS BIOSCIENCES INC financial stats to get the full picture.
No, 8C5 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 10, 2025, the company has 306.00 employees. See our rating of the largest employees — is COHERUS BIOSCIENCES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COHERUS BIOSCIENCES INC EBITDA is −112.87 M EUR, and current EBITDA margin is −73.63%. See more stats in COHERUS BIOSCIENCES INC financial statements.
Like other stocks, 8C5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COHERUS BIOSCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COHERUS BIOSCIENCES INC technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COHERUS BIOSCIENCES INC stock shows the sell signal. See more of COHERUS BIOSCIENCES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.